Literature DB >> 9585141

Stimulatory effect of paeoniflorin on adenosine A-1 receptors to increase the translocation of protein kinase C (PKC) and glucose transporter (GLUT 4) in isolated rat white adipocytes.

C W Lai1, F L Hsu, J T Cheng.   

Abstract

In an attempt to understand the subcellular signals after activation of adenosine A-1 receptors, paeoniflorin was employed to incubate with rat white adipocytes in vitro. Translocation of protein kinase C (PKC) beta-subtype from cytosol to membrane was enhanced by an incubation with paeoniflorin in a concentration-dependent manner similar to that of porcine insulin. Also, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) inhibited this action of paeoniflorin in a concentration-related fashion and it markedly attenuated the action of paeoniflorin at a concentrations sufficient to block the action of adenosine. Moreover, chelerythrine inhibited the paeoniflorin-stimulated translocation of PKC in a way similar to that stimulated by porcine insulin. Subcellular inhibition is considered because stimulation of porcine insulin was not modified by DPCPX at concentrations sufficient to block adenosine A-1 receptors. Similar results were also observed in adipocytes regarding the translocation of glucose transporter (GLUT4) from cytosol to membrane. Thus, we found that paeoniflorin can activate adenosine A-1 receptors to increase the translocations of PKC and GLUT4, two major signals for glucose uptake, from cytosol to membrane of the white adipocytes in rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585141     DOI: 10.1016/s0024-3205(98)00112-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists.

Authors:  Da-Zhi Liu; Ke-Qiang Xie; Xin-Quan Ji; Yang Ye; Cheng-Liang Jiang; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

3.  Role of adenosine in regulating glucose uptake during contractions and hypoxia in rat skeletal muscle.

Authors:  W Derave; P Hespel
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

4.  Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses.

Authors:  Ruo-Bing Guo; Guo-Feng Wang; An-Peng Zhao; Jun Gu; Xiu-Lan Sun; Gang Hu
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

5.  Evaluation of the In Vivo Therapeutic Effects of Radix Paeoniae Rubra Ethanol Extract with the Hypoglycemic Activities Measured from Multiple Cell-Based Assays.

Authors:  Chia-Chuan Chang; Wei Yuan; Yun-Lian Lin; Ren-Shyan Liu; Yi-Chen Juan; Wan-Hua Sun; Huey Jen Tsay; Hsiu-Chen Huang; Yu-Ching Lee; Hui-Kang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-29       Impact factor: 2.629

6.  Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome.

Authors:  Xiu Zhou; Sherouk Fouda; Xiao-Yi Zeng; Dongli Li; Kun Zhang; Jun Xu; Ji-Ming Ye
Journal:  Front Pharmacol       Date:  2019-10-11       Impact factor: 5.810

Review 7.  Plant and fungi derived analgesic natural products targeting voltage-gated sodium and calcium channels.

Authors:  Aida Calderon-Rivera; Santiago Loya-Lopez; Kimberly Gomez; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 3.493

8.  Paeoniflorin inhibits pulmonary artery smooth muscle cells proliferation via upregulating A2B adenosine receptor in rat.

Authors:  Guoqing Qian; Jin Cao; Chan Chen; Liangxing Wang; Xiaoying Huang; Cheng Ding; Xueding Cai; Fengying Yin; Jinguo Chu; Guoxiang Li; Jinyan Ye
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.